ERBB2 and breast carcinoma: Breast cancer patients often have different positive (+) or negative (−) statuses for the Estrogen Receptor (ER), Progesterone Receptor (PR), Human Epidermal Growth Factor receptor 2 (HER2), which are used to define breast cancer subtypes.